Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "operational-PAT"

3 News Found

Strides posts record Q3 EBITDA of Rs. 235.9 crore, operational PAT Up 39% YoY
News | February 02, 2026

Strides posts record Q3 EBITDA of Rs. 235.9 crore, operational PAT Up 39% YoY

Profitability metrics showed a sharper upward trend. Gross margin expanded 280 basis points to 61.2%


Strides Pharma reports  Rs. 24,897 million revenue during FY26, 2% YoY growth
Biopharma | May 18, 2026

Strides Pharma reports Rs. 24,897 million revenue during FY26, 2% YoY growth

Ex-US revenue rose sharply by 21% YoY to Rs. 22,404 million ($254 million); Operational PAT grew 50.3% YoY to Rs. 5,181 million


Strides Pharma Science report Q1 FY26 PAT at Rs. 105.6 Cr
News | August 05, 2025

Strides Pharma Science report Q1 FY26 PAT at Rs. 105.6 Cr

EBITDA rose to Rs. 218.1 crore, a 14.8% year-on-year increase